Among these five candidates, FUS (fused in sarcoma) was the most essential gene (βWT = 0.17; βRBKO = −0.61) in the initial CRISPR screen of ER+/RBKO cells (Fig. 4C; Supplementary Table 1). This evidence concerns the gene FUS and sarcoma.